Cullinan Oncology (CGEM) stock forecast for 2022 – 2027

Are you interested in Cullinan Oncology, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CGEM stock price in 2022-2027. Is CGEM a good long term stock? When should I take profit in Cullinan Oncology stock? Buy or sell stock? Will CGEM stock price go up? What are analysts’ forecasts for CGEM stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CGEM stock returns are also predicted based on historical data.

According to our research, CGEM stock is a outstanding long-term investment. CGEM share price has been in a bull cycle for the past year. Cullinan Oncology, Inc. stock trend is positive.

Cullinan Oncology company info

Industry Biotechnology
Address One Main Street, Cambridge, MA, 02142, United States
Website https://www.cullinanoncology.com

Forecasting

52 Week High: 19.7329 USD
52 Week Low: 13.3185 USD
1 Year Forecast: 18.9591 USD
5 Year Forecast: 43.6172 USD

Agilent Technologies info

Market Cap: 588.87M
52 Week Change: -20.904%
52 Week High: 59.85 USD
52 Week Low: 11.87 USD
Beta: 1.89337
50 Day Moving Average: 14.8
90 Day Moving Average: 16.873
200 Day Moving Average: 21.76
Resistance Level: 14.2208
Pivot Point: 13.5966
Support Level: 12.8573
Enterprise Value: 412,760,032
Forward P/E: -6.17
Forward EPS: -2.08
Profit Margin: 0.00%
Shares Outstanding: 43,684,500
EBITDA: -6.58
Held Percent Institutions: 86.15%
PEG Ratio (5Y): 0
Trailing EPS: -2.25

Cullinan Oncology stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Cullinan Oncology Stock Forecast for 2022

March 2022 15 13.86 -7.6%
April 2022 14 0 -100%
May 2022 0 15.3 -100%
June 2022 15 12.74 -15.07%
July 2022 12.87 0 -100%
August 2022 13.72 16.32 18.95%
September 2022 16.32 15.68 -3.92%
October 2022 0 15.68 -3.92%
November 2022 15.68 15.84 1.02%
December 2022 15.84 0 -100%

Cullinan Oncology Stock Forecast for 2023

January 2023 0 18.81 -100%
February 2023 18.62 20.79 11.65%
March 2023 21.21 19.8 -6.65%
April 2023 0 0 -6.65%
May 2023 20 20.79 3.95%
June 2023 20.58 18.81 -8.6%
July 2023 0 20.2 -8.6%
August 2023 20 22 10%
September 2023 22.22 0 -100%
October 2023 0 21.78 -100%
November 2023 22 22.22 1%
December 2023 22 0 -100%

Cullinan Oncology Stock Forecast for 2024

January 2024 21.56 25 15.96%
February 2024 25.25 26.46 4.79%
March 2024 26.73 0 -100%
April 2024 26.26 26.26 0%
May 2024 26.26 27.54 4.87%
June 2024 0 0 4.87%
July 2024 25 25.74 2.96%
August 2024 26.52 28 5.58%
September 2024 28.28 27.27 -3.57%
October 2024 28.56 27.72 -2.94%
November 2024 27.72 27.44 -1.01%
December 2024 27.72 27.44 -1.01%

Cullinan Oncology Stock Forecast for 2025

January 2025 28 31.62 12.93%
February 2025 30.69 32.34 5.38%
March 2025 33 32.32 -2.06%
April 2025 32 32 0%
May 2025 32.64 32 -1.96%
June 2025 32.32 30.38 -6%
July 2025 31.31 32.64 4.25%
August 2025 32.64 34.34 5.21%
September 2025 34.34 33 -3.9%
October 2025 33.66 34.68 3.03%
November 2025 34.34 33.32 -2.97%
December 2025 34 34.34 1%

Cullinan Oncology Stock Forecast for 2026

January 2026 34 35.64 4.82%
February 2026 36.63 39.78 8.6%
March 2026 38.61 37.24 -3.55%
April 2026 37.62 38.38 2.02%
May 2026 37.62 38.38 2.02%
June 2026 38.76 37.37 -3.59%
July 2026 36.26 38 4.8%
August 2026 38.76 40.8 5.26%
September 2026 40.4 38.61 -4.43%
October 2026 39.39 39.2 -0.48%
November 2026 39.6 39.2 -1.01%
December 2026 40.4 40.4 0%

Cullinan Oncology Stock Forecast for 2027

January 2027 39.2 41.58 6.07%